Skip to main content

Table 1 Grading of recommendations from Guyatt and colleagues [[1],[2]]

From: 2013 WSES guidelines for management of intra-abdominal infections

Grade of recommendation

Clarity of risk/benefit

Quality of supporting evidence

Implications

1A

   

Strong recommendation, high-quality evidence

Benefits clearly outweigh risk and burdens, or vice versa

RCTs without important limitations or overwhelming evidence from observational studies

Strong recommendation, applies to most patients in most circumstances without reservation

1B

   

Strong recommendation, moderate-quality evidence

Benefits clearly outweigh risk and burdens, or vice versa

RCTs with important limitations (inconsistent results, methodological flaws, indirect or imprecise) or exceptionally strong evidence from observational studies

Strong recommendation, applies to most patients in most circumstances without reservation

1C

   

Strong recommendation, low-quality or very low-quality evidence

Benefits clearly outweigh risk and burdens, or vice versa

Observational studies or case series

Strong recommendation based on limited evidence; recommendations may change when higher quality or more extensive evidence becomes available

2A

   

Weak recommendation, high-quality evidence

Benefits closely balanced with risks and burdens

RCTs without important limitations or overwhelming evidence from observational studies

Weak recommendation, best action may differ depending on circumstances, expertise of clinician, the patient in question, or other social issues

2B

   

Weak recommendation, moderate-quality evidence

Benefits closely balanced with risks and burdens

RCTs with important limitations (inconsistent results, methodological flaws, indirect or imprecise) or exceptionally strong evidence from observational studies

Weak recommendation, best action may differ depending on circumstances, expertise of clinician, the patient in question, or other social issues

2C

   

Weak recommendation, Low-quality or very low-quality evidence

Uncertainty in the estimates of benefits, risks, and burdens; benefits, risks, and burdens may be closely balanced

Observational studies or case series

Very weak recommendation; other alternatives may be equally reasonable